Common Contracts
5 similar Assignment of Rights Under Royalty Agreement contracts by Accentia Biopharmaceuticals Inc
EX-10.5 6 dex105.htm ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENT ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENTAssignment of Rights Under Royalty Agreement • May 5th, 2020
THIS ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENT (this “Assignment”), dated as of June 18, 2008, is entered into by and among Accentia Biopharmaceuticals, Inc., a Florida corporation (“Assignor”), Valens Offshore SPV I, Ltd. (“Assignee”) and Biovest International, Inc., a Delaware corporation (“Biovest”).
ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENTAssignment of Rights Under Royalty Agreement • June 20th, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
THIS ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENT (this “Assignment”), dated as of June 18, 2008, is entered into by and among Accentia Biopharmaceuticals, Inc., a Florida corporation (“Assignor”), Valens Offshore SPV I, Ltd. (“Assignee”) and Biovest International, Inc., a Delaware corporation (“Biovest”).
ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENTAssignment of Rights Under Royalty Agreement • June 20th, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
THIS ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENT (this “Assignment”), dated as of June 18, 2008, is entered into by and among Accentia Biopharmaceuticals, Inc., a Florida corporation (“Assignor”), PSource Structured Debt Limited (“Assignee”) and Biovest International, Inc., a Delaware corporation (“Biovest”).
ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENTAssignment of Rights Under Royalty Agreement • June 20th, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
THIS ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENT (this “Assignment”), dated as of June 18, 2008, is entered into by and among Accentia Biopharmaceuticals, Inc., a Florida corporation (“Assignor”), Valens U.S. SPV I, LLC (“Assignee”) and Biovest International, Inc., a Delaware corporation (“Biovest”).
ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENTAssignment of Rights Under Royalty Agreement • June 20th, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
THIS ASSIGNMENT OF RIGHTS UNDER ROYALTY AGREEMENT (this “Assignment”), dated as of June 18, 2008, is entered into by and among Accentia Biopharmaceuticals, Inc., a Florida corporation (“Assignor”), Erato Corp. (“Assignee”) and Biovest International, Inc., a Delaware corporation (“Biovest”).
